Evotec SE (EVO) Other Non Operating Income (2009 - 2025)
Evotec SE (EVO) posted Other Non Operating Income of $1393.5 for Q3 2025, up 111.24% sequentially from -$12398.9 in Q3 2024, and up 111.24% YoY from $659.69 in Q3 2024.
Evotec SE (EVO) Other Non Operating Income (2009 - 2025) Analysis & Trends
Evotec SE has reported Other Non Operating Income for 9 years, with the latest figure at $1393.5 in Q3 2025.
- Quarterly Other Non Operating Income rose 111.24% year-over-year to $1393.5 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$19855.5 (down 119.7% YoY) and the FY2022 annual result came in at $145895.4, up 51.83% from the prior year.
- Other Non Operating Income rose to $1393.5 in Q3 2025 per EVO's latest filing, from -$12398.9 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $122025.7 in Q4 2022 and troughed at -$13641.0 in Q2 2023.
- A 5-year average of $18621.6 and a median of $2923.8 in 2022 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income soared 1070.58% in 2022, then plunged 358.8% in 2024.
- Over 5 years, Other Non Operating Income stood at $88859.1 in 2021, then jumped by 37.32% to $122025.7 in 2022, then slumped by 96.07% to $4790.9 in 2023, then slumped by 358.8% to -$12398.9 in 2024, then jumped by 111.24% to $1393.5 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $1393.5, -$12398.9, and $4790.9 for Q3 2025, Q3 2024, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Evotec SE | 687.23 Mn | 686.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,393.51 |
| Sep 30, 2024 | -12,398.90 |
| Sep 30, 2023 | 4,790.89 |
| Jun 30, 2023 | -13,640.96 |
| Dec 31, 2022 | 122,025.67 |
| Sep 30, 2022 | 2,032.68 |
| Jun 30, 2022 | 22,056.06 |
| Mar 31, 2022 | 796.86 |
| Dec 31, 2021 | 88,859.09 |
| Sep 30, 2021 | 3,814.99 |
| Jun 30, 2021 | -2,272.46 |
| Mar 31, 2021 | 6,002.23 |
| Dec 31, 2020 | -8.26 Mn |
| Sep 30, 2020 | -3,154.98 |
| Dec 31, 2019 | 1.35 Mn |
| Sep 30, 2010 | 628.85 |
| Jun 30, 2010 | 639.97 |
| Mar 31, 2010 | 162.01 |
| Dec 31, 2009 | 1.77 Mn |
| Jun 30, 2009 | 599.13 |